MRK# Stock
t*r
1 楼
FDA panel to review ZONTIVITY for the proposed indication of reduction of
atherothrombotic events in patients with a history of myocardial infarction,
1/15. 有人关注么?
atherothrombotic events in patients with a history of myocardial infarction,
1/15. 有人关注么?